YLYanzhang Luo

Yanzhang Luo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yanzhang Luo has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Jiahui Guo

    Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China; and

    4 shared publications
  • Tong Wang

    MOE Key Laboratory of Tumor Molecular Biology, and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, the First Affiliated Hospital, Jinan University, Guangzhou, China

    4 shared publications
  • Wanling Zhang

    Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China; and

    4 shared publications
  • Dayu Liu

    Department of Laboratory Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China; Guangdong Engineering Technology Research Center of Microfluidic Chip Medical Diagnosis, Guangzhou, 510180, China

    3 shared publications
  • Jueming Chen

    Department of Laboratory Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, Guangdong, China

    2 shared publications
  • Qing-Yu He

    MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China

    2 shared publications

Latest Publications

  • Repeated exposure of anticancer agents to tumorspheres in open-surface microwell arrays for modeling chemotherapy-induced dormancy in colorectal cancer

    by Hui Kang, Xiaogang Wang, Weijie Ye, Yanzhang Luo, Jueming Chen, Ziqing Ma, Jiayu Li, Lihui Wang, Dongguo Lin, Dayu Liu

    Tumorspheres in open-surface microwell arrays were repeatedly exposed to an anticancer drug combination to investigate the biological responses and dormancy characteristics of colorectal cancer cells within.

  • TCIA: A Transformer-CNN Model With Illumination Adaptation for Enhancing Cell Image Saliency and Contrast

    by Jietao Yang, Guoheng Huang, Yanzhang Luo, Xiaofeng Zhang, Xiaochen Yuan, Xuhang Chen, Chi-Man Pun, Mu-Yan Cai

    Inconsistent illumination across imaging instruments poses significant challenges for accurate cell detection and analysis. Conventional methods (e.g. histogram equalization and basic filtering) struggle to adapt to complex lighting conditions, resulting in limited image enhancement and inconsistent performance. To address these issues, we propose the Transformer-CNN Illumination Adaptation (TCIA) model, which improves cell image saliency and contrast. By extracting Illumination Invariant Features (IIF) using a locally sensitive histogram as prior knowledge, our model effectively adapts to varying illumination conditions. The TCIA framework employs Hybrid Convolution Blocks (HCB) to extract and preserve essential features from image pairs, followed by a two-branch decomposition-fusion network that separates features into low-frequency and high-frequency components. The Lite-Transformer (LT) captures global context for low-frequency features, while the Circular Difference Invertible (CDI) module focuses on fine-grained textures and edges. These features are then fused and reconstructed to produce high-contrast, salient images. Extensive experiments on three datasets (MoNuSeg, MoNuSAC, and our contributed MTGC) demonstrate that TCIA outperforms existing methods in image fusion and cell detection, achieving an average improvement in detection accuracy 2%. This work provides a robust and innovative solution for enhanced cell imaging, contributing to more precise diagnostics and analysis. The source code will be available at https://github.com/Mrzhans/TCIA.


  • Selective expansion of renal cancer stem cells using microfluidic single-cell culture arrays for anticancer drug testing

    by Xiaogang Wang, Tao He, Zihe Chen, Jueming Chen, Yanzhang Luo, Dongguo Lin, Xiancheng Li, Dayu Liu

    The suboptimal prognosis associated with drug therapy for renal cancer can be attributed to the presence of stem-cell-like renal cancer cells. However, the limited number of these cells prevents conventional drug screening assays from effectively assessing the response of renal cancer stem cells to anti-cancer agents. To address this issue, the present study employed microfluidic single-cell culture arrays to expand renal cancer stem cells by exploiting the anti-apoptosis and self-renewal properties of tumor stem cells. A microfluidic chip with 18 000 hydrophilic microwells was designed and fabricated to establish the single-cell culture array. Over a 7 day culture, the large-scale single-cell culture yielded a limited quantity of single-cell-derived tumorspheres. The sphere formation rates for Caki-1, 786-O, and ACHN cells were determined to be 8.74 ± 0.53%, 12.02 ± 1.43%, and 4.98 ± 1.68%, respectively. The expanded cells exhibited stemness characteristics, as indicated by immunofluorescence, flow cytometry, serial passaging, and in vitro differentiation assays. Additionally, the comparative transcriptomic analysis showed significant differences in the gene expression patterns of the expanded cells compared to the differentiated renal cancer cells. The drug testing indicated that renal cancer stem cells exhibited reduced sensitivity towards the tyrosine kinase inhibitors sorafenib and sunitinib, compared to differentiated renal cancer cells. This reduced sensitivity can be attributed to the elevated expression levels of tyrosine kinase in renal cancer stem cells. This present study provides evidence that the utilization of microfluidic single-cell culture arrays for selective cell expansion can facilitate drug testing of renal cancer stem cells.


  • Active droplet-array microfluidics-based chemiluminescence immunoassay for point-of-care detection of procalcitonin

    by Enqi Huang, Dezhi Huang, Yu Wang, Dongyang Cai, Yanzhang Luo, Zhimin Zhong, Dayu Liu


  • Deep Coverage Tissue and Cellular Proteomics Revealed IL-1β Can Independently Induce the Secretion of TNF-Associated Proteins from Human Synoviocytes

    by Shengquan Tang, Suyuan Deng, Jiahui Guo, Xing Chen, Wanling Zhang, Yizhi Cui, Yanzhang Luo, Ziqi Yan, Qing-Yu He, Shan Shen, et al.

    Synovitis is a key contributor to the inflammatory environment in osteoarthritis (OA) joints. Currently, the biological therapy of OA is not satisfactory in multiple single-target trials on anti-TNF agents, or IL-1 antagonists. Systems biological understanding of the phosphorylation state in OA synovium is warranted to direct further therapeutic strategies. Therefore, in this study, we compared the human synovial phosphoproteome of the OA with the acute joint fracture subjects. We found that OA synovium had significantly more phosphoproteins, and 82 phosphoproteins could only be specifically found in all the OA samples. Differentially expressed proteins of the OA synovium were focusing on endoplasmic reticulum–/Golgi-associated secretion and negative regulation of cell proliferation, which was verified through an IL-1β–treated human synoviocyte (HS) in vitro model. With data-independent acquisition–based mass spectrometry, we found that IL-1β could induce HS to secrete proteins that were significantly associated with the endosomal/vacuolar pathway, endoplasmic reticulum/Golgi secretion, complement activation, and collagen degradation. Especially, we found that while specifically suppressing HS endocytosis, IL-1β could activate the secretion of 25 TNF-associated proteins, and the change of SERPINE2 and COL3A1 secretion was verified by immunoblotting. In conclusion, our results suggest that OA synovium has a polarized phosphoproteome to inhibit proliferation and maintain active secretion of HS, whereas IL-1β alone can transform HS to produce a synovitis-associated secretome, containing numerous TNF-associated secretory proteins in a TNF-independent mode.


  • Open Access

    SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma

    by Yanzhang Luo, Tin Seak Mok, Xiuxian Lin, Wanling Zhang, Yizhi Cui, Jiahui Guo, Xing Chen, Tao Zhang, Tong Wang

    Nasopharyngeal carcinoma (NPC) is a serious threat to public health, and the biomarker discovery is of urgent needs. The data-independent mode (DIA) based sequential window acquisition of all theoretical fragment-ion spectra (SWATH) mass spectrometry (MS) has been proved to be precise in protein quantitation and efficient for cancer biomarker researches. In this study, we performed the first SWATH-MS analysis comparing the NPC and normal tissues. Spike-in stable isotope labeling by amino acids in cell culture (super-SILAC) MS was used as a shotgun reference. We identified and quantified 1414 proteins across all SWATH-MS analyses. We found that SWATH-MS had a unique feature to preferentially detect proteins with smaller molecular weights than either super-SILAC MS or human proteome background. With SWATH-MS, 29 significant differentially express proteins (DEPs) were identified. Among them, carbonic anhydrase 2 (CA2) was selected for further validation per novelty, MS quality and other supporting rationale. With the tissue microarray analysis, we found that CA2 had an AUC of 0.94 in differentiating NPC from normal tissue samples. In conclusion, SWATH-MS has unique features in proteome analysis, and it leads to the identification of CA2 as a potentially new diagnostic biomarker for NPC.


  • Phosphoproteome Characterization of Human Colorectal Cancer SW620 Cell-Derived Exosomes and New Phosphosite Discovery for C-HPP

    by Jiahui Guo, Yizhi Cui, Ziqi Yan, Yanzhang Luo, Wanling Zhang, Suyuan Deng, Shengquan Tang, Gong Zhang, Qing-Yu He, Tong Wang

    Identification of all phosphorylation forms of known proteins is a major goal of the Chromosome-Centric Human Proteome Project (C-HPP). Recent studies have found that certain phosphoproteins can be encapsulated in exosomes and function as key regulators in tumor microenvironment, but no deep coverage phosphoproteome of human exosomes has been reported to date, which makes the exosome a potential source for the new phosphosite discovery. In this study, we performed highly optimized MS analyses on the exosomal and cellular proteins isolated from human colorectal cancer SW620 cells. With stringent data quality control, 313 phosphoproteins with 1091 phosphosites were confidently identified from the SW620 exosome, from which 202 new phosphosites were detected. Exosomal phosphoproteins were significantly enriched in the 11q12.1–13.5 region of chromosome 11 and had a remarkably high level of tyrosine-phosphorylated proteins (6.4%), which were functionally relevant to ephrin signaling pathway-directed cytoskeleton remodeling. In conclusion, we here report the first high-coverage phosphoproteome of human cell-secreted exosomes, which leads to the identification of new phosphosites for C-HPP. Our findings provide insights into the exosomal phosphoprotein systems that help to understand the signaling language being delivered by exosomes in cell–cell communications. The mass spectrometry proteomics data have been deposited to the ProteomeXchange consortium with the data set identifier PXD004079, and iProX database (accession number: IPX00076800).